Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-02 Sale | 2022-08-04 6:24 pm | Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director | 11,341 | $0.1901 | $2,156 | 10,384 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 9:07 pm | Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director | 1,125 | $1.2 | $1,350 | 21,725 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-18 Option Award | 2024-07-19 4:56 pm | N/A 2034-07-17 | Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director | 2,125 | $0 | 2,125 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 4:17 pm | 2024-05-23 2034-05-23 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 67,000 | $0 | 67,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 5:19 pm | N/A 2033-06-21 | Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director | 42,500 | $0 | 42,500 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-26 4:22 pm | 2023-05-24 2033-05-24 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:33 pm | N/A 2032-06-21 | Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director | 28,000 | $0 | 28,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:17 pm | 2022-05-25 2032-05-25 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2021-07-28 Option Award | 2021-07-30 8:23 pm | N/A 2031-07-27 | Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director | 52,500 | $0 | 57,850 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-24 5:55 pm | N/A 2031-06-22 | Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 4:25 pm | 2021-06-03 2031-06-03 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:54 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director | 52,500 | $0 | 88,500 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-25 6:48 pm | N/A 2030-06-24 | Cidara Therapeutics Inc. | CDTX | BURGESS DANIEL D Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-01 4:56 pm | 2020-05-28 2030-05-28 | Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director | 22,000 | $0 | 22,000 (Direct) | View |